Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:57 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 13,909 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Cellulite
Interventions: cryolipolysis, Subcision, Control; Device · Procedure · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Heavy Drinking, Alcohol Drinking, Substance Use, Drinking Behavior
Interventions: Standard Brief Intervention, Trauma-Informed and Peer-Supported Brief Intervention, Assessment only; Behavioral
Lead sponsor: Western Kentucky University; Other
Eligibility: 18 Years to 25 Years
Enrollment: 284 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Bowling Green, Kentucky

Conditions: Polycystic Ovary Syndrome, Infertility
Interventions: Progestin, Clomiphene Citrate; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Infection, Human Immunodeficiency Virus
Interventions: BMS-663068 400 mg, BMS-663068 800 mg, BMS-663068 600 mg, BMS-663068 1200 mg, Raltegravir 400 mg, Tenofovir 300 mg, Ritonavir 100 mg, Atazanavir 300 mg; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 254 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 13
States / cities: San Francisco, California • Washington D.C., District of Columbia • Coral Gables, Florida + 9 more

Conditions: COVID-19, Vaccine Hesitancy, Health Misinformation, Communication
Interventions: Gamified misinformation refutation quiz, Refutational text (active control); Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 3,637 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Pregnancy, Gestational Diabetes Mellitus, Class A2, Neonatal Hypoglycemia
Interventions: Blood sugar check every 2 hours, Blood sugar check every 4 hours; Other
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Falls Church, Virginia

Conditions: Uterine Cervical Neoplasms, Uterine Neoplasms, Ovarian Neoplasms, Urogenital Neoplasms, Fallopian Tube Neoplasms
Interventions: Guided Imagery With Audio Media; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Suicidal Ideation, Suicide Attempt
Interventions: Smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S), Smartphone-delivered inactive Therapeutic Evaluative Conditioning; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cutaneous Tumors, Mohs Micrographic Surgery
Interventions: Norco 5Mg-325Mg Tablet, Suzetrigine; Drug
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 89 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Smoking Cessation
Interventions: Quitxt text messaging or Chat, Usual care; Behavioral · Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 29 Years
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Abortion Late, Pain
Interventions: Local anesthetic for tenaculum placement, Sham, Paracervical Block, Dilator Placement, Post-procedural assessment, Preprocedural pain control; Procedure · Behavioral · Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older · Female only
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 2
States / cities: San Diego, California

Conditions: Heart Failure
Interventions: Spironolactone; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Type 2 Diabetes
Interventions: HM11260C, liraglutide, Placebo; Drug
Lead sponsor: Hanmi Pharmaceutical Company Limited; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 254 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: CA, California

Conditions: Obesity, Type 2 Diabetes
Interventions: G4H-Diab-Nano; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 10 Years to 12 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Fracture of Radius and Ulna
Interventions: Cast; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 3 Years to 18 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Ovarian Cancer
Interventions: Fermented Wheat Germ Extract (FWGE), Placebo, Standard of Care: Planned Surgery, Quality of Life (QoL) Surveys: FACT-O; Drug · Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Frailty
Interventions: PAUSE Intervention; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 35,015 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: Palo Alto, California • Nashville, Tennessee • Houston, Texas

Conditions: Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT)
Interventions: Edoxaban, Standard of Care; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 1 Day to 17 Years
Enrollment: 290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 22
States / cities: Tucson, Arizona • Los Angeles, California • Stanford, California + 16 more

Conditions: Anterior Cruciate Ligament Tear
Interventions: BEAR Scaffold, Tendon Graft; Device · Procedure
Lead sponsor: Miach Orthopaedics; Industry
Eligibility: 14 Years to 35 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sensorimotor Gait Disorder, Neurologic Ambulation Disorder, Gait, Drop Foot, Poststroke Hemiparesis, Post-Cerebrovascular Accident (CVA) Hemiparesis
Interventions: Ness L300, Ankle-foot orthosis; Device
Lead sponsor: Bioness Inc; Industry
Eligibility: 18 Years and older
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 11
States / cities: Downey, California • Long Beach, California • San Diego, California + 8 more

Conditions: Hip Fracture
Interventions: Navigated, Conventional; Procedure
Lead sponsor: AO Clinical Investigation and Publishing Documentation; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Abnormal Uterine Bleeding, Analgesia, Paracervical Block
Interventions: paracervical block, Lidocaine, ketorolac; Procedure · Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Mechanical Low Back Pain
Interventions: Prescriptive Mobilization, Pragmatic Mobilization; Procedure
Lead sponsor: Walsh University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 3
States / cities: Des Moines, Iowa • North Canton, Ohio • Youngstown, Ohio

Conditions: Chronic Pain, Obesity, Sedentary Lifestyle
Interventions: MORPH; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years to 79 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Search by objective public record fields.

Cryolipolysis and Subcision for Treatment of Cellulite

A Brief Intervention for Alcohol Users With Interpersonal Trauma

Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

Online Games to Help Canadian and U.S. Adults Identify COVID-19 and Vaccine Misinformation: Three Sequential Randomized Studies

Intrapartum Glycemic Control in GDMA2

Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients

A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior

Suzetrigine vs Norco-postoperative Mohs Pain

Quitxt Mobile Text Messaging Cessation Research Study

Paracervical Block for Pain Control With Osmotic Dilator Placement

Novel Treatment for Diastolic Heart Failure in Women

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Video Games for Obesity and Diabetes Prevention-Diab & Nano

Randomized Control Trial: Elbow Extension Versus Flexion Cast in Proximal Half Both Bone Forearm Fractures

Fermented Wheat Germ Extract in Women With Ovarian Cancer

PAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE)

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Bridge-Enhanced ACL Repair vs ACL Reconstruction

Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop

Accuracy of Navigation in Placement of Sacroiliac Screw

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

Prescriptive Mobilization Versus a Pragmatic Mobilization

A Mobile Intervention to Reduce Pain and Improve Health (MORPH)